BELLEVUE, Wash., Oct. 9, 2018 -- Univar Inc. (NYSE: UNVR) ("Univar"), a global chemical and ingredient distributor and provider of value-added services, announced today that its wholly owned subsidiary, ChemPoint.com, Inc. ("ChemPoint"), has expanded its relationship with PMC Biogenix to include distribution in Mexico, effective September, 2018. Services ChemPoint will manage include order placement, fulfillment, and technical support in Mexico for PMC's Kemamide®, Armoslip®, Hystrene®, and Industrene®, branded products along with the metallic stearate portfolio.
"We are pleased to have expanded our partnership with PMC, allowing ChemPoint to work as an extension of the company to meet the needs of the market in Mexico," said ChemPoint managing director, Rick Hoener. "Our innovative digital tools can reach new potential customers across market niches, generating and capturing demand for PMC's products."
With a leading portfolio of specialty chemical products produced from renewable resources, PMC's slip agents, anti-block additives and fatty acids should benefit from ChemPoint's unique business model that focuses on demand creation, which includes finding, engaging, retaining and nurturing customers on a large scale. "It's clear that PMC had a strong need for excellent technical acumen and a deep understanding of their business, which ChemPoint offers," said Hoener. The PMC products are known in the industry for their high quality and wide-range of uses in sensitive applications.
About Univar Inc.
Founded in 1924, Univar (NYSE: UNVR) is a global chemical and ingredient distributor and provider of value-added services, working with leading suppliers worldwide. Supported by a comprehensive team of sales and technical professionals with deep specialty and market expertise, Univar operates hundreds of distribution facilities throughout North America, Western Europe, Asia-Pacific and Latin America. Univar delivers tailored customer solutions through a broad product and services portfolio sustained by one of the most extensive industry distribution networks in the world. For more information, visit Univar.com. Follow us on Twitter at twitter.com/Univar and like us on Facebook at facebook.com/Univar.
ChemPoint.com, Inc., a wholly owned subsidiary of Univar Inc., is a unique distribution business that provides marketing and sales services for specialty and fine chemicals in North America EMEA and LATAM. The company engages in exclusive product line relationships with premier manufacturers, providing tailored solutions to more than 90 supplier partners and over 200 product lines globally. For more information, please visit www.chempoint.com.
PMC Biogenix has been the pioneer in the development and manufacture of primary amides worldwide. They offer over fifty years of development and manufacturing of oleochemical derivatives. Product offerings include fatty acids, fatty esters, triglycerides, glycerin approved for pharmaceutical applications, glycerol esters, amides, bisamides, and stearates. With a 16,000 square-foot facility in Memphis, Tennessee, their Center for Renewable Chemistry (CDC) is a cornerstone for product, process and application development efforts. This center includes a technical center and pilot scale manufacturing facility. PMC's dedication and commitment to the chemical industry ensures customer's perceived and un-perceived needs are well met.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek," "comfortable with," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.